# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CareDx will be sharing its long-term growth strategy during an Investor Day in October 2024.
Wells Fargo analyst Brandon Couillard initiates coverage on CareDx (NASDAQ:CDNA) with a Underweight rating and announces Pri...
BTIG analyst Sung Ji Nam upgrades CareDx (NASDAQ:CDNA) from Neutral to Buy and announces $40 price target.
Goldman Sachs analyst Matthew Sykes maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $16 to $26.
Craig-Hallum analyst Connor Chamberlain maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $22 to $32.
HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.